FDA
-
-
-
-
-
-
-
Talphera secures up to $29 million in private placement financing
-
-
-
-
-
-
-
Talphera Announces First Quarter 2025 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Talphera (TLPH) Announces Agreement with the FDA for Prior Approval Supplement Review to Reduce the Number of Patients in the NEPHRO CRRT Study
-
-
-
-
-
-
-
Talphera (TLPH) Announces First Patient Enrolled in the Registrational Trial Evaluating Nafamostat for Anticoagulation of the Extracorporeal Circuit
-
-
-
-
-
-
-
Talphera to Host First Quarter 2024 Financial Results Call and Webcast on Tuesday, May 14, 2024
-
-
-
-
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

